2nd Quarter - Report

GOVERNMENT COUNSEL, LLC for PRIME THERAPEUTICS

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 1895-Lower Health Care Costs ActSection 306;S. 2543-The Prescription Drug Pricing Reduction Act (PDPRA) of 2019; H.R. 3-Lower Drug Costs Now Act of 2019 relating to pharmacy DIR;H.R. 748-Coronavirus Aid, Relief, and Economic Security Act relating to pharmacy DIR;H.R. 6800- Health and Economic Recovery Omnibus Emergency Solutions Act (HERO); 21st Century CURES 2.0 relating to value-based purchasing.

LobbyistCovered position, as disclosed
HENRY W MENN Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (116th), H.R. 6800 (116th), S. 1895 (116th), H.R. 748 (116th), S. 2543 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.